Bone Mineral Content Growth and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide The Randomized IMPAACT 2010 VESTED Trial

dc.article.end-page219en
dc.article.start-page211en
dc.citation.doi10.1097/QAI.0000000000003656en
dc.contributor.authorTapiwa Mbengeranwaen
dc.contributor.authorLauren Ziembaen
dc.contributor.authorSean Brummelen
dc.contributor.authorBen Johnstonen
dc.contributor.authorHaseena Cassimen
dc.contributor.authorLee Fairlieen
dc.contributor.authorE et alen
dc.date.accessioned2026-04-21T12:00:58Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1525-4135en
dc.identifier.urihttps://hdl.handle.net/10539/49087
dc.journal.titleBone Mineral Content Growth and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide The Randomized IMPAACT 2010 VESTED Trialen
dc.journal.volume99en
dc.publisherPORTLAND PRESS LTDen
dc.titleBone Mineral Content Growth and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide The Randomized IMPAACT 2010 VESTED Trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
643.68 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client